Medical significance of peroxisome proliferator-activated receptors

This publication has 60 references indexed in Scilit:

• L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ
  Published by Elsevier ,1999
• Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
  New England Journal of Medicine, 1998
• The Peroxisome Proliferator-Activated Receptor α (PPARα) Ligand WY 14,643 Does Not Interfere with Leukotriene B4 Induced Adhesion of Neutrophils to Endothelial Cells
  Biochemical and Biophysical Research Communications, 1998
• Up-Regulation of UCP-2 Gene Expression by PPAR Agonists in Preadipose and Adipose Cells
  Biochemical and Biophysical Research Communications, 1997
• Troglitazone
  Drugs, 1997
• The Orphan Nuclear Hormone Receptor LXRα Interacts with the Peroxisome Proliferator-activated Receptor and Inhibits Peroxisome Proliferator Signaling
  Published by Elsevier ,1996
• Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
  Journal of Clinical Investigation, 1995
• mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
  Genes & Development, 1994
• Effect of various n − 3/n − 6 fatty acid ratio contents of high fat diets on rat liver and heart peroxisomal and mitochondrial β-oxidation
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)
  Biology of the Cell, 1993